These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19060722)

  • 41. New findings in mood and anxiety disorders are important for health insurers.
    Lieber AL
    J Insur Med; 1992; 24(2):97-101. PubMed ID: 10171567
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of maternal anxiety in the early postpartum period: screening for anxiety and depressive symptomatology in Greece.
    Giakoumaki O; Vasilaki K; Lili L; Skouroliakou M; Liosis G
    J Psychosom Obstet Gynaecol; 2009 Mar; 30(1):21-8. PubMed ID: 19308779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevalence of trauma-related disorders in the French WHO study: Santé mentale en population générale (SMPG)].
    Vaiva G; Jehel L; Cottencin O; Ducrocq F; Duchet C; Omnes C; Genest P; Rouillon F; Roelandt JL
    Encephale; 2008 Dec; 34(6):577-83. PubMed ID: 19081454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?
    Ortega-Hernandez OD; Cuccia M; Bozzini S; Bassi N; Moscavitch S; Diaz-Gallo LM; Blank M; Agmon-Levin N; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():589-99. PubMed ID: 19758204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pain-related anxiety and anxiety sensitivity across anxiety and depressive disorders.
    Carleton RN; Abrams MP; Asmundson GJ; Antony MM; McCabe RE
    J Anxiety Disord; 2009 Aug; 23(6):791-8. PubMed ID: 19362446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comorbidity and temporal ordering of alcohol use disorders and other psychiatric disorders: results from a Danish register-based study.
    Flensborg-Madsen T; Mortensen EL; Knop J; Becker U; Sher L; Grønbaek M
    Compr Psychiatry; 2009; 50(4):307-14. PubMed ID: 19486728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining and sequencing medication and cognitive-behaviour therapy for childhood anxiety disorders.
    Keeton CP; Ginsburg GS
    Int Rev Psychiatry; 2008 Apr; 20(2):159-64. PubMed ID: 18386206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evolutionary concepts of affective disorders].
    Rybakowski F; Rybakowski J
    Psychiatr Pol; 2006; 40(3):401-13. PubMed ID: 17037808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sexual disorders in subjects treated for mood and anxiety diseases.
    Bossini L; Fagiolini A; Valdagno M; Polizzotto NR; Castrogiovanni P
    J Clin Psychopharmacol; 2007 Jun; 27(3):310-2. PubMed ID: 17502785
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of family structure, the TPH2 G-703T and the 5-HTTLPR serotonergic genes upon affective problems in children aged 10-14 years.
    Nobile M; Rusconi M; Bellina M; Marino C; Giorda R; Carlet O; Vanzin L; Molteni M; Battaglia M
    J Child Psychol Psychiatry; 2009 Mar; 50(3):317-25. PubMed ID: 19175813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Rapkin AJ; Mikacich JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):455-63. PubMed ID: 18797268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin transporter gene variants and behavior: a comprehensive review.
    Serretti A; Calati R; Mandelli L; De Ronchi D
    Curr Drug Targets; 2006 Dec; 7(12):1659-69. PubMed ID: 17168841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generalized anxiety disorder: between now and DSM-V.
    Allgulander C
    Psychiatr Clin North Am; 2009 Sep; 32(3):611-28. PubMed ID: 19716993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developments in the treatment and diagnosis of anxiety disorders.
    Wittchen HU; Gloster AT
    Psychiatr Clin North Am; 2009 Sep; 32(3):xiii-xix. PubMed ID: 19716986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
    Schatzberg AF; Weiss RD; Brady KT; Culpepper L
    CNS Spectr; 2008 Apr; 13(4 Suppl 6):3. PubMed ID: 18408653
    [No Abstract]   [Full Text] [Related]  

  • 57. Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.
    Goodman DW; Thase ME
    Postgrad Med; 2009 Sep; 121(5):20-30. PubMed ID: 19820271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Drug therapy of anxiety].
    Leinonen E; Lepola U; Koponen H
    Duodecim; 2000; 116(24):2855-64. PubMed ID: 12077891
    [No Abstract]   [Full Text] [Related]  

  • 59. Psychosocial and clinical predictors of response to pharmacotherapy for depression.
    Bagby RM; Ryder AG; Cristi C
    J Psychiatry Neurosci; 2002 Jul; 27(4):250-7. PubMed ID: 12174734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing sophistication of the pharmacotherapy of mood disorders.
    Joffe RT
    J Psychiatry Neurosci; 2002 Mar; 27(2):89. PubMed ID: 11944509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.